Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-06

Clinical Trial Update: Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intramuscular epinephrine as an adjunctive treatment for severe pediatric asthma exacerbations has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: University of Louisville | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2021-07-06